First held as the Angioplasty Summit by Dr. Seung-Jung Park in 1995, TCTAP has been recognized as the best international academic conference in the field of interventional cardiovascular medicine in the Asia-Pacific region. TCTAP features in-depth programs through active academic exchanges and collaborations with the departments of cardiology, thoracic surgery, radiology, vascular surgery, pediatric cardiology, and cardiac rehabilitation, which have made significant contributions to the development of international cardiology therapies.
TCTAP embraces the latest knowledge from the East to the West, contributing to the improvement of treatments for patients around the world suffering from heart disease through academic program exchanges with global groups including AP CTO, CCT, CIAT, CIT, CRF, HKSTENT, ISIC, Malaysia LIVE, TTT, QICC, among others.
TCTAP, held annually at the end of April in Seoul, Korea, provides attendees with the opportunity to review the latest basic and clinical investigations that provide guidance on optimally managing patients with coronary or structural heart disease, integrate the newest interventional techniques and devices related to patient care in the coronary, peripheral, and structural heart disease, compare and contrast different approaches to the hot debates among masters of interventional cardiology, Integrate adjunctive pharmacologic management in treating patients with cardiovascular disease, and much more.
- Interventional cardiologists
- General cardiologists
- Physicians interested in cardiology and vascular medicine
- Basic scientists
- Vascular medicine specialists
- Vascular surgeons
- Cardiac surgeons
- Interventional pediatricians
- Nurses and technologists
- Other health care professionals with special interest in interventional vascular therapy and medicine
TCTAP is organized by CardioVasucular Research Foundation (CVRF) and supported by Heart Institute of Asan Medical Center (Seoul, Korea), and partially funded by educational grants from commercial supporters.
The CardioVascular Research Foundation wishes to extend special appreciation to Clinical Research Center for Ischemic Heart Disease for their continued support to our programs.